Going Beyond the Classic Management of Cutaneous Squamous Cell Carcinoma: Anti-PD1 Therapy

Going Beyond the Classic Management of Cutaneous Squamous Cell Carcinoma: Anti-PD1 Therapy is organized by Med Learning Group.

Learning Objectives:
• Discuss the elements of immune dysfunction that drive the tumorigenesis of cutaneous squamous cell carcinoma (cSCC)
• Review risk stratification of patients with cutaneous squamous cell carcinoma to determine who is at high risk of recurrence
• Describe the application of medical practice guidelines and supporting trial data to the treatment of patients with locally advanced and metastatic cSCC

Additional details will be posted as soon as information is available.